Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Inflammation and Brain Function Study
NCT03294564Phase 1Completed
- Sponsor
- University of California, San Francisco
- Start
- Jan 2018
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of salmonella typhi capsular polysaccharide vaccine in typhoid fever, sponsored by University of California, San Francisco. Primary endpoint: Inflammatory markers elicited by the typhoid vaccine. Started Jan 2018; status: completed.
02
Drugs
salmonella typhi capsular polysaccharide vaccine
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT03294564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03294564.